Table 1. Reported and estimated incidence and prevalence of cutaneous leishmaniasis, 2002–2015.
Author | Study year | Reported | Estimated |
||
---|---|---|---|---|---|
Incidence | Prevalence | Incidence | Prevalence |
||
Mathers et al. [14] |
2002 |
- |
- |
1,157,000 |
2,157,000 |
Alvar et al. [15] |
2002–2009 | 214,036 | - | 1,213,300 | - |
WHO WER [16] |
2014 | 154,649* | - | - | - |
WHO GHO [17] |
2005–2015 | 187,855* (mean) | 2,066,410* (11 years) | - | - |
GBD 2010 [18] |
2010 |
- |
- |
- |
10,000,000 |
GBD 2013 [19] |
2013 | - | - | - | 3,914,800* |
GBD 2015 [20] | 2015 | - | - | - | 3,895,900* |
N.B. The studies below the dotted line (...) refer to Global Burden of Disease (GBD) studies conducted by the Institute of Health Metrics and Evaluation (IHME)
*MCL included
Abbreviations: GBD, Global Burden of Disease; GHO, Global Health Observatory; WER, Weekly Epidemiological Record